急性与危重症期间心房颤动研究的优先方向:急性与危重症心房颤动研讨会的建议
心房颤动是急性与危重症中常见的心律失常,与不良的短期和长期结局相关。针对该人群预防、预测和治疗心房颤动的研究具有很大潜在获益,但研究面临独特挑战,导致指导管理的证据基础稀疏。主要障碍包括缺乏统一定义、难以设计捕捉复杂病因和评估因果的研究、缺乏清晰的结局集、在急性环境中招募面临时机、知情同意和工作流程方面的困难,以及未能将研究嵌入临床照护平台并利用新兴技术。研讨会建议研究人员、临床医生和利益相关者协作应对这些挑战,通过跨学科合作优化研究效率并倡导推进对这一常见复杂心律失常的认识,以改善患者照护和结局。
要点
- 急性与危重症心房颤动与不良短期和长期结局相关,但指导管理的证据基础稀疏。
- 研究主要障碍包括缺乏统一定义、难以捕捉复杂病因和评估因果、缺乏清晰结局集。
- 在急性环境中招募面临时机、知情同意和工作流程方面的困难。
- 未能将研究嵌入临床照护平台并利用新兴技术也是重要障碍。
- 研讨会建议研究人员、临床医生和利益相关者协作,通过跨学科合作优化研究效率并倡导推进认识。
适用人群与场景
- 急性与危重症患者中发生心房颤动的人群。
研究设计与关键结果
- 研讨会识别出急性与危重症心房颤动研究的主要障碍:缺乏统一定义、难以设计捕捉复杂病因和评估因果的研究、缺乏清晰的结局集、在急性环境中招募面临时机、知情同意和工作流程方面的困难,以及未能将研究嵌入临床照护平台并利用新兴技术。
- 研讨会建议研究人员、临床医生和利益相关者协作应对这些挑战,通过跨学科合作优化研究效率并倡导推进对这一常见复杂心律失常的认识,以改善患者照护和结局。
证据类型、等级与局限
- 证据类型:研讨会建议(专家意见)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- Symposium on Atrial Fibrillation in Acute and Critical Care(急性与危重症心房颤动研讨会)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Atrial fibrillation (AF) is a common arrhythmia encountered in acute and critical illness and is associated with poor short and long-term outcomes. Given the consequences of developing AF, research into prevention, prediction and treatment of this arrhythmia in the critically ill are of great potential benefit, however, study of AF in critically ill patients faces unique challenges, leading to a sparse evidence base to guide management in this population. Major obstacles to the study of AF in acute and critical illness include absence of a common definition, challenges in designing studies that capture complex etiology and assess causality, lack of a clear outcome set, difficulites in recruitment in acute environments with respect to timing, consent, and workflow, and failure to embed studies into clinical care platforms and capitalize on emerging technologies. Collaborative effort by researchers, clinicians, and stakeholders should be undertaken to address these challenges, both through interdisciplinary cooperation for the optimization of research efficiency and advocacy to advance the understanding of this common and complex arrhythmia, resulting in improved patient care and outcomes. The Symposium on Atrial Fibrillation in Acute and Critical Care was convened to address some of these challenges and propose potential solutions.
参考来源
- Sibley S, Atzema C, Balik M, et al. Research priorities for the study of atrial fibrillation during acute and critical illness: recommendations from the Symposium on Atrial Fibrillation in Acute and Critical Care. BMC Proc. 2024. PMID: 39497129. doi:10.1186/s12919-024-00309-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。